GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Gross-Profit-to-Asset %

Universal Ibogaine (TSXV:IBO) Gross-Profit-to-Asset % : 37.81% (As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Universal Ibogaine's annualized Gross Profit for the quarter that ended in Jan. 2025 was C$1.49 Mil. Universal Ibogaine's average Total Assets over the quarter that ended in Jan. 2025 was C$3.94 Mil. Therefore, Universal Ibogaine's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2025 was 37.81%.


Universal Ibogaine Gross-Profit-to-Asset % Historical Data

The historical data trend for Universal Ibogaine's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Gross-Profit-to-Asset % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial - - 25.15 17.43 46.55

Universal Ibogaine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.35 39.32 45.49 39.90 37.81

Competitive Comparison of Universal Ibogaine's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Universal Ibogaine's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Gross-Profit-to-Asset % falls into.


;
;

Universal Ibogaine Gross-Profit-to-Asset % Calculation

Universal Ibogaine's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jul. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jul. 2024 )/( (Total Assets (A: Jul. 2023 )+Total Assets (A: Jul. 2024 ))/ count )
=2.331/( (5.502+4.513)/ 2 )
=2.331/5.0075
=46.55 %

Universal Ibogaine's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jan. 2025 )/( (Total Assets (Q: Oct. 2024 )+Total Assets (Q: Jan. 2025 ))/ count )
=1.488/( (4.088+3.783)/ 2 )
=1.488/3.9355
=37.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jan. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Universal Ibogaine Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines